D. Schwartz et al., ROLE OF NITRIC-OXIDE (EDRF) IN RADIOCONTRAST ACUTE-RENAL-FAILURE IN RATS, The American journal of physiology, 267(3), 1994, pp. 60000374-60000379
This study was undertaken to examine the possible role of endothelium-
derived relaxing factor (EDRF), identified as nitric oxide (NO), in th
e pathogenesis of radiocontrast-induced acute renal failure in rats. N
ormal and salt-depleted rats were monitored for 60 min or 24 h after r
adiocontrast administration. The administration of L-arginine to norma
l rats abolished the immediate decrease in p-aminohippurate clearance
(C-PAH) and attenuated the decrease in inulin clearance (C-In). The ad
ministration of NO synthase inhibitor to the salt-depleted animals res
ulted in a significantly more pronounced decrease in C-PAH compared wi
th both the control and the L-arginine-treated animals. The recovery o
f C-In 24 h after radiocontrast administration to the salt-depleted ra
ts was significantly better in the L-arginine-treated rats than in eit
her the control or inhibitor-treated groups. The administration of rad
iocontrast material resulted in a significant decrease in urinary guan
osine 3',5'-cyclic monophosphate as well as NO2 + NO3 excretion. This
decrease was significantly attenuated by L-arginine. Our results 1) su
ggest that NO plays a major role in the pathogenesis of radiocontrast-
induced acute renal failure and 2) suggest a novel therapeutic approac
h, i.e., the use of L-arginine in this form of acute renal failure.